CAHCardinal Health$246.45Mizuho
RatingOutperform unchanged
Price target$250 → $280 +12.0% · +$30
Price at note$257.55 (Oct 20 close) +8.7% upside (+$22.45) to the $280 target
Third-party analyst actions
Analyst moves
Upgrades, downgrades, new coverage and price-target changes from Wall Street firms on the stocks we cover. What each firm published, laid out plainly. These are third-party actions, not our views.
Showing every move on file for CAHClear search
28 moves
ⓘ Rating colors
- Strong BuyConviction Buy, Top Pick, Top Pick Buy
- BuyLong Term Buy, Speculative Buy, Outright Buy
- OutperformOverweight, Accumulate, Moderate Buy, Positive
- HoldNeutral, Equal Weight, Market Perform, Sector Perform
- UnderperformUnderweight, Reduce, Moderate Sell, Negative
- Sell
- Strong Sell
- OtherRatings we can't place on the scale
Each firm's own wording is placed on one seven-step scale so ratings compare at a glance. ▲ / ▼ between two ratings marks an upgrade or a downgrade. The colours describe what the firm said; they are not our view.
Tuesday · Oct 20, 2026
CAHCardinal Health$246.45Friday · Oct 16, 2026
CAHCardinal Health$246.45UBS
RatingBuy unchanged
Price target$280 → $295 +5.4% · +$15
Price at note$254.06 (Oct 16 close) +16.1% upside (+$40.94) to the $295 target
Thursday · Aug 13, 2026
CAHCardinal Health$246.45TD Cowen
RatingBuy unchanged
Price target$275 → $280 +1.8% · +$5
CAHCardinal Health$246.45JP Morgan
RatingNeutral unchanged
Price target$215 → $260 +20.9% · +$45
CAHCardinal Health$246.45Barclays
RatingOverweight unchanged
Price target$258 → $275 +6.6% · +$17
Wednesday · Aug 12, 2026
CAHCardinal Health$246.45Citigroup
RatingBuy unchanged
Price target$265 → $280 +5.7% · +$15
CAHCardinal Health$246.45Evercore ISI Group
RatingOutperform unchanged
Price target$265 → $270 +1.9% · +$5
CAHCardinal Health$246.45Morgan Stanley
RatingOverweight unchanged
Price target$255 → $265 +3.9% · +$10
CAHCardinal Health$246.45Mizuho
RatingOutperform unchanged
Price target$240 → $250 +4.2% · +$10
CAHCardinal Health$246.45UBS
RatingBuy unchanged
Price target$274 → $280 +2.2% · +$6
CAHCardinal Health$246.45Wells Fargo
RatingOverweight unchanged
Price target$245 → $277 +13.1% · +$32
CAHCardinal Health$246.45Baird
RatingOutperform unchanged
Price target$251 → $274 +9.2% · +$23
Friday · Jul 24, 2026
CAHCardinal Health$246.45Citigroup
RatingBuy unchanged
Price target$245 → $265 +8.2% · +$20
Thursday · Jul 23, 2026
CAHCardinal Health$246.45Mizuho
RatingOutperform unchanged
Price target$235 → $240 +2.1% · +$5
Monday · Jul 20, 2026
CAHCardinal Health$246.45UBS
RatingBuy unchanged
Price target$260 → $274 +5.4% · +$14
Thursday · Jul 9, 2026
CAHCardinal Health$246.45TD Cowen
RatingBuy unchanged
Price target$255 → $275 +7.8% · +$20
Thursday · Jul 2, 2026
CAHCardinal Health$246.45B of A Securities
RatingBuy unchanged
Price target$240 → $260 +8.3% · +$20
Monday · May 4, 2026
CAHCardinal Health$246.45JP Morgan
RatingNeutral unchanged
Price target$243 → $215 −11.5% · −$28
Friday · May 1, 2026
CAHCardinal Health$246.45Citigroup
RatingBuy unchanged
Price target$249 → $245 −1.6% · −$4
CAHCardinal Health$246.45TD Cowen
RatingBuy unchanged
Price target$251 → $255 +1.6% · +$4
CAHCardinal Health$246.45Wells Fargo
RatingOverweight unchanged
Price target$256 → $245 −4.3% · −$11
Wednesday · Apr 8, 2026
CAHCardinal Health$246.45Evercore ISI Group
RatingOutperform unchanged
Price target$260 → $240 −7.7% · −$20
Tuesday · Feb 24, 2026
CAHCardinal Health$246.45Barclays
RatingOverweight unchanged
Price target$243 → $258 +6.2% · +$15
Tuesday · Feb 10, 2026
CAHCardinal Health$246.45JP Morgan
RatingNeutral unchanged
Price target$209 → $243 +16.3% · +$34
CAHCardinal Health$246.45Wells Fargo
RatingOverweight unchanged
Price target$237 → $256 +8.0% · +$19
Friday · Feb 6, 2026
CAHCardinal Health$246.45Mizuho
RatingOutperform unchanged
Price target$222 → $235 +5.9% · +$13
Thursday · Jan 29, 2026
CAHCardinal Health$246.45Morgan Stanley
RatingOverweight unchanged
Price target$224 → $245 +9.4% · +$21
Thursday · Jan 15, 2026
CAHCardinal Health$246.45Wells Fargo
RatingOverweight unchanged
Price target$221 → $237 +7.2% · +$16
Source: Yahoo Finance analyst upgrades and downgrades (firm, rating, price target), refreshed after each US market close for the stocks SURVYR. covers. Yahoo doesn't name the individual analyst. "Price at note" is that day's closing price from our daily price history (the prior close when the note came before the open); the upside or downside is the distance from it to the new target. Details opens the matching news story when we have one, otherwise the stock's Yahoo Finance analysis page. Ratings and targets belong to the firms named; SURVYR. doesn't rate stocks, set targets or give advice. Not investment advice · Important disclosures
Get the market emails
Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdaysIndexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.
Check your inbox to confirm
We sent a link to . Tap it to start your emails. Nothing is sent until you confirm.
Not there in a minute? Check spam, or .
Dev mode No email provider here, so the confirm link is shown: Open confirm link
SURVYR
Free to use. No card, no ads, no auto-renew.
Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app
Coteau 0.9 · Oct 21, 2026